Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vogirite M 500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Foregen Healthcare Ltd

Salt Composition

Metformin (500mg) + Voglibose (0.2mg)

Overview Vogirite M 500mg/0.2mg Tablet SR

Diabexe Duo 500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, which includes a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Possible side effects, such as nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes, are typically transient and self-limiting. Persistent or concerning side effects warrant immediate medical attention. Your doctor can offer strategies to manage or treat bothersome side effects. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Vogirite M 500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Vogirite M 500mg/0.2mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Vogirite M 500mg/0.2mg sustained-release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Vogirite M 500mg/0.2mg Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Vogirite M 500mg/0.2mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vogirite M 500mg/0.2mg Extended-Release Tablet with food.

How Vogirite M 500mg/0.2mg Tablet SR works:

Extended-release Vogirite M tablets (500mg/0.2mg) contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Vogirite M 500mg/0.2mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Vogirite M 500mg/0.2mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Vogirite M 500mg/0.2mg tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Vogirite M 500mg/0.2mg Tablet SR. Nevertheless, patients using this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Exercise caution when administering Vogirite M 500mg/0.2mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Vogirite M 500mg/0.2mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended throughout the treatment period.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Vogirite M 500mg/0.2mg sustained-release tablets in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Vogirite M 500mg/0.2mg Tablet SR :

Should you forget to take a Vogirite M 500mg/0.2mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vogirite M 500mg/0.2mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Vogirite M 500mg/0.2mg Ta...
73
MRP 89
17% off